交易中 09-16 10:57:47 美东时间
-1.470
-1.20%
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
今天 09:48
Barrington Research analyst Vincent Colicchio maintains Insight Enterprises (NASDAQ:NSIT) with a Outperform and maintains $164 price target.
09-15 19:46
Insight Enterprises (NASDAQ:NSIT) has outperformed the market over the past 5 y...
09-02 22:45
Insight Enterprises's (NYSE:NSIT) short percent of float has risen 10.48% since...
08-01 03:00
Gainers VerifyMe (NASDAQ:VRME) stock rose 80.5% to $1.24 during Thursday's reg...
08-01 01:07
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
Major earnings expected before the bell on Thursday include: AbbVie (OTC:ABBY) Bristol-Myers Squibb Company (BMY) Mastercard Incorporated (MA) CVS Health Corporation (CVS) Shell plc (SHEL) Other earni...
07-31 06:00
Insight Enterprises (NASDAQ:NSIT) is set to give its latest quarterly earnings ...
07-31 02:01
Insight Enterprises (NASDAQ:NSIT) has outperformed the market over the past 20 ...
07-25 22:30
今日重点评级关注:花旗:维持百度"买入"评级,目标价从138美元升至140美元;Maxim Group:维持Caledonia Mining"买入"评级,目标价从21美元升至28美元
07-18 09:25